Brief: Alzinova: Status Update Regarding Application To Start Clinical Study With ALZ-101
22/04/2021 07:04
April 22(Reuters) - Alzinova AB ALZ.ST :
* SAID ON WEDNESDAY DOCUMENTATION REQUIRED FOR THE
APPLICATION TO
START THE PLANNED PHASE 1B CLINICAL STUDY WITH THE DRUG
CANDIDATE ALZ-101 WILL BE READY DURING JUNE
* FIRST PATIENT FIRST DOSE (FPFD) WILL NOT BE ADMINISTERED
DURING
THIS QUARTER AS PREVIOUSLY COMMUNICATED
* STUDY IS INSTEAD EXPECTED TO START DURING Q3, PLAN TO
ADMINISTER
THE FPFD IN THE SAME QUARTER, PROVIDED THAT THE COVID-19
SITUATION IN FINLAND ALLOWS FOR THAT
Source text for Eikon: urn:newsml:reuters.com:*:nWkr2NrKG5
Further company coverage: ALZ.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00))